James Engelhart
Director/Board Member presso Our Lady of Mercy Academy
Profilo
James Engelhart, CPA, è un direttore finanziario e tesoriere della Biohaven Pharmaceutical Holding Co. Ltd. È nel consiglio di amministrazione della Our Lady of Mercy Academy. Il signor Engelhart è stato precedentemente impiegato come direttore esecutivo-finanziario presso Alexion Pharmaceuticals, Inc., direttore finanziario presso Energizer SpinCo, Inc. e revisore presso Coopers & Lybrand LLP. Si è laureato presso la Villanova University e ha conseguito una laurea presso la Villanova School of Business.
Posizioni attive di James Engelhart
Società | Posizione | Inizio |
---|---|---|
Our Lady of Mercy Academy | Director/Board Member | - |
Precedenti posizioni note di James Engelhart
Società | Posizione | Fine |
---|---|---|
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Director of Finance/CFO | 15/12/2021 |
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2016 |
ENERGIZER HOLDINGS, INC. | Corporate Officer/Principal | 01/07/2014 |
Coopers & Lybrand LLP | Corporate Officer/Principal | 01/01/1991 |
Formazione di James Engelhart
Villanova School of Business | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ENERGIZER HOLDINGS, INC. | Consumer Non-Durables |
Aziende private | 4 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Coopers & Lybrand LLP | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
Our Lady of Mercy Academy |
- Borsa valori
- Insiders
- James Engelhart